Harbin Gloria Pharmaceuticals (002437) — Cash Flow-to-Debt Ratio
Harbin Gloria Pharmaceuticals (002437) has a Cash Flow-to-Debt Ratio of 0.21x as of September 2025, meaning its operating cash flow of CN¥182.89 Million could theoretically repay 0% of its total liabilities (CN¥852.18 Million) in one year. See cash generation quality of Harbin Gloria Pharmaceuticals to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Harbin Gloria Pharmaceuticals Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Harbin Gloria Pharmaceuticals across 19 annual periods. Also explore Harbin Gloria Pharmaceuticals (002437) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Harbin Gloria Pharmaceuticals (2007–2025)
Year-by-year debt coverage analysis for Harbin Gloria Pharmaceuticals. For market capitalisation and broader financial context, see 002437 market cap.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | CN¥273.36 Million | CN¥825.00 Million | ▼ -31.3% |
| 2024 | 0.48x | CN¥410.94 Million | CN¥852.26 Million | ▲ +153.6% |
| 2023 | 0.19x | CN¥274.18 Million | CN¥1.44 Billion | ▲ +72.3% |
| 2022 | 0.11x | CN¥261.62 Million | CN¥2.37 Billion | ▲ +9.3% |
| 2021 | 0.10x | CN¥274.18 Million | CN¥2.72 Billion | ▲ +1943.0% |
| 2020 | 0.00x | CN¥12.76 Million | CN¥2.58 Billion | ▼ -96.1% |
| 2019 | 0.13x | CN¥610.37 Million | CN¥4.82 Billion | ▼ -44.6% |
| 2018 | 0.23x | CN¥1.16 Billion | CN¥5.08 Billion | ▲ +68.9% |
| 2017 | 0.14x | CN¥651.80 Million | CN¥4.81 Billion | ▼ -39.9% |
| 2016 | 0.23x | CN¥1.04 Billion | CN¥4.62 Billion | ▲ +55.4% |
| 2015 | 0.14x | CN¥702.05 Million | CN¥4.85 Billion | ▼ -60.9% |
| 2014 | 0.37x | CN¥674.04 Million | CN¥1.82 Billion | ▼ -62.0% |
| 2013 | 0.98x | CN¥453.02 Million | CN¥464.60 Million | ▼ -3.5% |
| 2012 | 1.01x | CN¥205.89 Million | CN¥203.79 Million | ▼ -9.7% |
| 2011 | 1.12x | CN¥128.61 Million | CN¥114.91 Million | ▼ -26.7% |
| 2010 | 1.53x | CN¥112.59 Million | CN¥73.73 Million | ▲ +38.5% |
| 2009 | 1.10x | CN¥170.82 Million | CN¥154.95 Million | ▲ +62.4% |
| 2008 | 0.68x | CN¥57.81 Million | CN¥85.17 Million | ▲ +0.2% |
| 2007 | 0.68x | CN¥52.26 Million | CN¥77.15 Million | — |